{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:08:56Z","timestamp":1793909336378,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Undergraduate Innovation and Entrepreneurship Training Program of Xinjiang Medical Universit","award":["grant no. X202410760047"],"award-info":[{"award-number":["grant no. X202410760047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04981-5","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:08:15Z","timestamp":1780470495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fusobacterium nucleatum exacerbates chronic atrophic gastritis in rats via mitochondrial dysfunction and inflammatory activation"],"prefix":"10.1186","volume":"26","author":[{"given":"Peixun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizinaer","family":"Abula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adili","family":"Abudourousuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"3","key":"4981_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1615\/jenvironpatholtoxicoloncol.2018026839","volume":"37","author":"Y Li","year":"2018","unstructured":"Li Y, Xia R, Zhang B, Li C. Chronic atrophic gastritis: A review. J Environ Pathol Toxicol Oncol. 2018;37(3):241\u201359. https:\/\/doi.org\/10.1615\/jenvironpatholtoxicoloncol.2018026839.","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"7","key":"4981_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10654-010-9482-0","volume":"25","author":"MA Adamu","year":"2010","unstructured":"Adamu MA, Weck MN, Gao L, Brenner H. Incidence of chronic atrophic gastritis: Systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010;25(7):439\u201348. https:\/\/doi.org\/10.1007\/s10654-010-9482-0.","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"4981_CR3","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.cgh.2017.05.023","volume":"15","author":"M Rugge","year":"2017","unstructured":"Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017;15(12):1833\u201343. https:\/\/doi.org\/10.1016\/j.cgh.2017.05.023.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"4981_CR4","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1053\/j.gastro.2021.06.078","volume":"161","author":"SC Shah","year":"2021","unstructured":"Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA clinical practice update on the diagnosis and management of atrophic gastritis: Expert review. Gastroenterology. 2021;161(4):1325\u2013e13327. https:\/\/doi.org\/10.1053\/j.gastro.2021.06.078.","journal-title":"Gastroenterology"},{"issue":"5","key":"4981_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/00325481.2022.2063604","volume":"134","author":"H Yang","year":"2022","unstructured":"Yang H, Zhou X, Hu B. The \u2018reversibility\u2019 of chronic atrophic gastritis after the eradication of Helicobacter pylori. Postgrad Med. 2022;134(5):474\u20139. https:\/\/doi.org\/10.1080\/00325481.2022.2063604.","journal-title":"Postgrad Med"},{"issue":"47","key":"4981_CR6","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.3748\/wjg.v28.i47.6702","volume":"28","author":"Y Koga","year":"2022","unstructured":"Koga Y. Microbiota in the stomach and application of probiotics to gastroduodenal diseases. World J Gastroenterol. 2022;28(47):6702\u201315. https:\/\/doi.org\/10.3748\/wjg.v28.i47.6702.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4981_CR7","doi-asserted-by":"publisher","first-page":"e13013","DOI":"10.1111\/hel.13013","volume":"28","author":"F Zhu","year":"2023","unstructured":"Zhu F, Zhang X, Li P, Zhu Y. Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta-analysis. Helicobacter. 2023;28(6):e13013. https:\/\/doi.org\/10.1111\/hel.13013.","journal-title":"Helicobacter"},{"issue":"38","key":"4981_CR8","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.3748\/wjg.v20.i38.13842","volume":"20","author":"V Pasechnikov","year":"2014","unstructured":"Pasechnikov V. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol. 2014;20(38):13842\u201362. https:\/\/doi.org\/10.3748\/wjg.v20.i38.13842.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"4981_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/nejmoa1909666","volume":"382","author":"IJ Choi","year":"2020","unstructured":"Choi IJ, Kim CG, Lee JY, Kim Y-I, Kook M-C, Park B, et al. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020;382(5):427\u201336. https:\/\/doi.org\/10.1056\/nejmoa1909666.","journal-title":"N Engl J Med"},{"issue":"11","key":"4981_CR10","doi-asserted-by":"publisher","first-page":"e1006653","DOI":"10.1371\/journal.ppat.1006653","volume":"13","author":"BN Parsons","year":"2017","unstructured":"Parsons BN, Ijaz UZ, D\u2019Amore R, Burkitt MD, Eccles R, Lenzi L, et al. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathog. 2017;13(11):e1006653. https:\/\/doi.org\/10.1371\/journal.ppat.1006653.","journal-title":"PLoS Pathog"},{"issue":"2","key":"4981_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1742-7843.2005.pto960202.x","volume":"96","author":"TC Martinsen","year":"2005","unstructured":"Martinsen TC, Bergh K, Waldum HL. Gastric juice: A barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005;96(2):94\u2013102. https:\/\/doi.org\/10.1111\/j.1742-7843.2005.pto960202.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"4981_CR12","doi-asserted-by":"publisher","first-page":"e23357","DOI":"10.1096\/fj.202301648r","volume":"38","author":"L Zhou","year":"2024","unstructured":"Zhou L, Mao H, Li J, Chen Z, Zhang L. Fusobacterium nucleatum exacerbates the progression of pulpitis by regulating the STING-dependent pathway. FASEB J. 2024;38(1):e23357. https:\/\/doi.org\/10.1096\/fj.202301648r.","journal-title":"FASEB J"},{"issue":"1","key":"4981_CR13","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4981_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP-Y. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389. https:\/\/doi.org\/10.1038\/s41577-019-0165-0.","journal-title":"Nat Rev Immunol"},{"key":"4981_CR15","doi-asserted-by":"publisher","first-page":"122842","DOI":"10.1016\/j.biomaterials.2024.122842","volume":"314","author":"YS Son","year":"2025","unstructured":"Son YS, Kwon YH, Lee M-S, Kwon O, Jeong Y-J, Mun SJ, et al. Helicobacter pylori VacA-induced mitochondrial damage in the gastric pit cells of the antrum and therapeutic rescue. Biomaterials. 2025;314:122842. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122842.","journal-title":"Biomaterials"},{"key":"4981_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6175804","volume":"2019","author":"AV Snezhkina","year":"2019","unstructured":"Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS, et al. ROS generation and antioxidant defense systems in normal and malignant cells. Oxid Med Cell Longev. 2019;2019:1\u201317. https:\/\/doi.org\/10.1155\/2019\/6175804.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"4981_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.chom.2012.10.014","volume":"12","author":"H Tsugawa","year":"2012","unstructured":"Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, et al. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe. 2012;12(6):764\u201377. https:\/\/doi.org\/10.1016\/j.chom.2012.10.014.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"4981_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","volume":"17","author":"CA Brennan","year":"2019","unstructured":"Brennan CA, Garrett WS. Fusobacterium nucleatum \u2014 symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2019;17(3):156\u201366. https:\/\/doi.org\/10.1038\/s41579-018-0129-6.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"4981_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2015.01.010.","journal-title":"Immunity"},{"key":"4981_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fcimb.2017.00295","volume":"7","author":"J Abed","year":"2017","unstructured":"Abed J, Maalouf N, Parhi L, Chaushu S, Mandelboim O, Bachrach G. Tumor targeting by Fusobacterium nucleatum: A pilot study and future perspectives. Front Cell Infect Microbiol. 2017;7:295. https:\/\/doi.org\/10.3389\/fcimb.2017.00295.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"4981_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41579-025-01237-z","volume":"24","author":"SS Jiang","year":"2026","unstructured":"Jiang SS, Chen Y, X,Fang JY. Fusobacterium nucleatum: ecology, pathogenesis and clinical implications[J]. Nat Rev Microbiol. 2026;24(3):197\u2013214.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"4981_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/prd.12426","volume":"89","author":"T Alon-Maimon","year":"2022","unstructured":"Alon-Maimon T, Mandelboim O, Bachrach G. Fusobacterium nucleatum and cancer. Periodontol 2000. 2022;89(1):166\u201380. https:\/\/doi.org\/10.1111\/prd.12426.","journal-title":"Periodontol 2000"},{"issue":"2","key":"4981_CR23","first-page":"25","volume":"13","author":"B Signat","year":"2011","unstructured":"Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol. 2011;13(2):25\u201336.","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"4981_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207\u201315. https:\/\/doi.org\/10.1016\/j.chom.2013.07.007.","journal-title":"Cell Host Microbe"},{"key":"4981_CR25","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.2147\/ott.s194153","volume":"12","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Niu Q, Fan W, Huang F, He H. Oral microbiota and gastrointestinal cancer. OncoTargets Ther. 2019;12:4721\u20138. https:\/\/doi.org\/10.2147\/ott.s194153.","journal-title":"OncoTargets Ther"},{"issue":"16","key":"4981_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/ijms26167915","volume":"26","author":"J Sorino","year":"2025","unstructured":"Sorino J, Della Mura M, Ingravallo G, et al. Fusobacterium nucleatum and Gastric Cancer: An Emerging Connection[J]. Int J Mol Sci. 2025;26(16):416\u201331.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4981_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13104-025-07165-8","volume":"18","author":"N Kamali","year":"2025","unstructured":"Kamali N, Talebi Bezmin Abadi A, Rahimi F, et al. Fusobacterium nucleatum confirmed in gastric biopsies of patients without Helicobacter pylori[J]. BMC Res Notes. 2025;18(1):109.","journal-title":"BMC Res Notes"},{"issue":"3","key":"4981_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548\u2013e56316. https:\/\/doi.org\/10.1016\/j.cell.2017.07.008.","journal-title":"Cell"},{"issue":"2","key":"4981_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195\u2013206. https:\/\/doi.org\/10.1016\/j.chom.2013.07.012.","journal-title":"Cell Host Microbe"},{"issue":"6369","key":"4981_CR30","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358(6369):1443\u20138. https:\/\/doi.org\/10.1126\/science.aal5240.","journal-title":"Science"},{"issue":"10","key":"4981_CR31","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00262-018-2233-x","volume":"67","author":"T Chen","year":"2018","unstructured":"Chen T, Li Q, Wu J, Wu Y, Peng W, Li H, et al. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol Immunother. 2018;67(10):1635\u201346. https:\/\/doi.org\/10.1007\/s00262-018-2233-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"4981_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","volume":"152","author":"Y Yang","year":"2017","unstructured":"Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor\u2009\u2013 \u03baB, and up-regulating expression of MicroRNA-21. Gastroenterology. 2017;152(4):851\u2013e86624. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.018.","journal-title":"Gastroenterology"},{"issue":"1","key":"4981_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1089\/dna.2019.5064","volume":"39","author":"F Geng","year":"2020","unstructured":"Geng F, Zhang Y, Lu Z, Zhang S, Pan Y. Fusobacterium nucleatum caused DNA damage and promoted cell proliferation by the Ku70 \/ p53 pathway in oral cancer cells. DNA Cell Biol. 2020;39(1):144\u201351. https:\/\/doi.org\/10.1089\/dna.2019.5064.","journal-title":"DNA Cell Biol"},{"issue":"6","key":"4981_CR34","doi-asserted-by":"publisher","first-page":"e1581531","DOI":"10.1080\/2162402x.2019.1581531","volume":"8","author":"C Gur","year":"2019","unstructured":"Gur C, Maalouf N, Shhadeh A, Berhani O, Singer BB, Bachrach G, et al. Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. OncoImmunology. 2019;8(6):e1581531. https:\/\/doi.org\/10.1080\/2162402x.2019.1581531.","journal-title":"OncoImmunology"},{"issue":"1","key":"4981_CR35","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11(1):3259. https:\/\/doi.org\/10.1038\/s41467-020-16967-2.","journal-title":"Nat Commun"},{"issue":"10","key":"4981_CR36","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, et al. Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion[J]. Cancer Res. 2025;85(10):1819\u201341.","journal-title":"Cancer Res"},{"key":"4981_CR37","doi-asserted-by":"publisher","first-page":"644638","DOI":"10.3389\/fphar.2021.644638","volume":"12","author":"Y Tong","year":"2021","unstructured":"Tong Y, Liu L, Wang R, Yang T, Wen J, Wei S, et al. Berberine attenuates chronic atrophic gastritis induced by MNNG and its potential mechanism. Front Pharmacol. 2021;12:644638. https:\/\/doi.org\/10.3389\/fphar.2021.644638.","journal-title":"Front Pharmacol"},{"issue":"17","key":"4981_CR38","doi-asserted-by":"publisher","first-page":"6294","DOI":"10.3390\/molecules28176294","volume":"28","author":"Y He","year":"2023","unstructured":"He Y, Liu H-H, Zhou X-L, He T-T, Zhang A-Z, Wang X, et al. Rutaecarpine ameliorates murine N-methyl-N\u2019-nitro-N-nitrosoguanidine-induced chronic atrophic gastritis by sonic hedgehog pathway. Molecules. 2023;28(17):6294. https:\/\/doi.org\/10.3390\/molecules28176294.","journal-title":"Molecules"},{"issue":"7","key":"4981_CR39","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/cmi.12560","volume":"18","author":"FQ Bui","year":"2016","unstructured":"Bui FQ, Johnson L, Roberts J, et al. Fusobacterium nucleatum infection of gingival epithelial cells leads to NLRP3 inflammasome-dependent secretion of IL-1\u03b2 and the danger signals ASC and HMGB1[J]. Cell Microbiol. 2016;18(7):970\u201381.","journal-title":"Cell Microbiol"},{"issue":"11","key":"4981_CR40","doi-asserted-by":"publisher","first-page":"e0165701","DOI":"10.1371\/journal.pone.0165701","volume":"11","author":"B Tang","year":"2016","unstructured":"Tang B, Wang K, Jia YP, et al. Fusobacterium nucleatum-Induced Impairment of Autophagic Flux Enhances the Expression of Proinflammatory Cytokines via ROS in Caco-2 Cells[J]. PLoS ONE. 2016;11(11):e0165701.","journal-title":"PLoS ONE"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04981-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:01:25Z","timestamp":1786060885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04981-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4981"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04981-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study protocol was approved by the Animal Research Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Approval No.: IACUC-JT-20241015-07).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"489"}}